Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues

[1]  X. Puente,et al.  Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. , 1996, Cancer research.

[2]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII. , 1996, Neurology.

[3]  Hiroshi Sato,et al.  Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.

[4]  B. Hinzmann,et al.  cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. , 1995, European journal of biochemistry.

[5]  Hiroshi Sato,et al.  The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*) , 1995, The Journal of Biological Chemistry.

[6]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[7]  K. Murakami,et al.  Secretion of beta-amyloid precursor protein involves multiple cleavage sites. , 1994, The Journal of biological chemistry.

[8]  Miki Hasegawa,et al.  A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor , 1993, Nature.

[9]  D. Walker,et al.  Immunohistochemical localization of beta‐amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy , 1992, Journal of neuroscience research.

[10]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[11]  B. Haendler,et al.  Complementary DNA for human T‐cell cyclophilin. , 1987, The EMBO journal.